Mice infected by intraperitoneal inoculation of the RH strain of Toxoplasma gondii were treated with various drugs. Trimethoprim was found to have no effect. Sulphamethoxazole, sulphadiazine and pyrimethamine had significant therapeutic effects on the course of murine toxoplasmosis. The therapeutic efficacy of sulphamethoxazole was enhanced by the addition of trimethoprim. A pyrimethamine-sulphadiazine combination was found to be superior to a trimethoprim-sulphamethoxazole combination in the treatment of experimental murine toxoplasmosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

murine toxoplasmosis
8
chemotherapy experimental
4
experimental toxoplasmosis
4
toxoplasmosis comparison
4
comparison efficacy
4
efficacy trimethoprim-sulfur
4
trimethoprim-sulfur pyrimethamine-sulfur
4
pyrimethamine-sulfur combinations
4
combinations mice
4
mice infected
4

Similar Publications

Background: transmission can occur during pregnancy if the mother contracts the infection for the first time. Treatment strategies include the use of antimicrobial medications and providing supportive care. Spiramycin is commonly used to treat toxoplasmosis in pregnant women and to hinder the disease's transmission.

View Article and Find Full Text PDF

Programmed-cell death is an antimicrobial defense mechanism that promotes clearance of intracellular pathogens. Toxoplasma counteracts host immune defenses by secreting effector proteins into host cells; however, how the parasite evades lytic cell death and the effectors involved remain poorly characterized. We identified ROP55, a rhoptry protein that promotes parasite survival by preventing lytic cell death in absence of IFN-γ stimulation.

View Article and Find Full Text PDF

Protection induced by recombinant vaccinia virus targeting the ROP4 of Toxoplasma gondii in mice.

Exp Parasitol

January 2025

Department of Medical Zoology, School of Medicine, Kyung Hee University, Seoul, 02447, Republic of Korea; Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, Core Research Institute (CRI), Kyung Hee University, Seoul, 02447, Republic of Korea. Electronic address:

Toxoplasmosis is a parasitic disease affecting a significant portion of the global population, whose etiology can be attributed to the protozoan organism Toxoplasma gondii. Despite its public health importance, an efficacious vaccine to prevent human toxoplasmosis remains unavailable. To this end, we designed an experimental toxoplasmosis vaccine using recombinant vaccinia virus vectors (rVacv) expressing the T.

View Article and Find Full Text PDF

Goats are the one of the most susceptible domestic species to toxoplasmosis affecting animal health and production. The present study aimed to determine the seroprevalence of T. gondii infection in dairy goats from Rio de Janeiro, Brazil, as well as to evaluate associated risk factors, parasitic DNA detection in raw goat milk samples, and attempts to isolate the parasite from raw goat milk samples.

View Article and Find Full Text PDF

Background: Immunothrombosis is the process by which the coagulation cascade interacts with the innate immune system to control infection. However, the formation of clots within the brain vasculature can be detrimental to the host. Recent work has demonstrated that Toxoplasma gondii infects and lyses central nervous system (CNS) endothelial cells that form the blood-brain barrier (BBB).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!